ACADIA PHARMACEUTICALS INC ($ACAD)
Filing Information
| Accession Number | 0001568249-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
32,838
Total Value
$162,491.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, CHIEF LEGAL OFFICER, SEC | Common Stock | โ | Feb 6, 2026 | Exercise/Conversion | 12,944 | $0.00 | $0.00 | 14,559 | Direct | โ | View Details | |
EVP, CHIEF LEGAL OFFICER, SEC | Common Stock | โ | Feb 9, 2026 | Sale | 6,950 | $23.38 | $162,491.00 | 7,609 | Direct | โ | View Details | |
EVP, CHIEF LEGAL OFFICER, SEC | Restricted Stock Units | Derivative | Feb 6, 2026 | Exercise/Conversion | 12,944 | $0.00 | $0.00 | 12,945 | Direct | โ | View Details |